What’s the best way for pharma to reach patients in Europe?
May 12, 2010Medical Communications Digital Pharma Guide
Lisa first noticed the pain and stiffness in her hands when she was unable to hold heavy pots or to …
What is digital marketing? Not just another channel to market
May 12, 2010Medical Communications Digital Pharma Guide
The basic principles of marketing still apply: know your customer and your competitors, define your target segments and be clear …
Can Apple sweeten the taste of the Tablet?
May 12, 2010Medical Communications Apple, Digital Pharma Guide, ipad
The year is 1992. The Conservative Party, lead by John Major is re-elected. The Maastricht Treaty is signed, founding the …
Share your brand: go video, go social
May 12, 2010Medical Communications Digital Pharma Guide
It’s been a long time coming but finally justice is being done. Thanks to broadband, social media sites and video …
Developments in digital media
May 12, 2010Medical Communications Digital Pharma Guide, digital pharma
It seems everyone’s head these days is filled with Facebook, MySpace or Twitter, iPhone apps or the recently launched iPad, …
Pharma’s Digital Revolution – The Story So Far
May 12, 2010Medical Communications Digital Pharma Guide, FDA, Twitter, blog, community, digital pharma, ipad, social networking
The internet and digital communication are transforming all aspects of pharma’s work. From social media to drug discovery, here are …
Four new hires at Euro RSCG Life Medicom
May 12, 2010Medical Communications appointment, medical communications, medicom
Euro RSCG Life Medicom has four new starters to handle new international and domestic business. They are Antonia Ford (pictured left), …
GSK appoints Patrick Vallance
May 12, 2010Research and Development GSK, appointment, research and development
Patrick Vallance has been appointed as senior vice president, medicines discovery and development at GlaxoSmithKline, and as a member of …
GSK bolsters presence in South Korea
May 11, 2010Sales and Marketing Dong-A, GSK, Korea, em
GlaxoSmithKline has followed through with plans to expand into emerging markets by striking a co-marketing deal with South Korea’s largest …
Synexus appoints Germany and Poland managers
May 11, 2010Research and Development CRO, Synexus, appointment, research and development
Synexus has appointed Dr Helena Sigal as country manager for Germany and Radoslaw Janiak as country manager for Poland. Helena …
EMA transparency criticised
May 11, 2010Sales and Marketing EMA, Roaccutane, patient information
The European Medicines Agency (EMA) has been given a rap over the knuckles by the European Ombudsman for a perceived …
Calls for changes to trial publication process
May 11, 2010Medical Communications, Research and Development industry relations, industry reputation, publication
Clinical trial publishing has not kept pace with changes in the way pharma carries out its research, according to a …
Crucell malaria vaccine starts trials in Africa
May 11, 2010Research and Development Crucell, malaria
Dutch biopharma firm Crucell has started a phase I trial of its AdVac-based malaria vaccine in Burkina Faso, West Africa. …
Pfizer to cut jobs in New York
May 11, 2010Sales and Marketing Pfizer, job cuts
Pfizer is reportedly planning to cut or relocate up to 1,400 jobs in New York in its on-going restructuring programme. …
Doctors shunning pharma rep visits
May 11, 2010pharma, sales force, sales force effectiveness, sales representatives
More and more doctors in the US are refusing to see pharma companies’ sales representatives, according to new research. The …
Bayer colon cancer drug moves into phase III
May 11, 2010Research and Development Bayer, colorectal cancer, regorafenib
Bayer Schering Pharma will shortly begin phase III tests of its investigational compound regorafenib for patients with metastatic colorectal cancer. …
Merck gains rights to cancer treatment
May 10, 2010Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC
Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …
Anti-counterfeiting pilot a success, says EFPIA
May 10, 2010Sales and Marketing counterfeits, supply chain
A pilot project aimed at stopping counterfeit medicines getting into the supply chain has been a resounding success, according to …
Teva reports strong Q1 results
May 10, 2010Sales and Marketing 2010 financials, Teva
Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …
Professor Sander van Deventer appointed to AMT supervisory board
May 10, 2010Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development
Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
